Apogee Therapeutics IPO Indicating $22.10 On 321K Shares; IPO Priced At $17/Share On 17.65M Shares
Portfolio Pulse from Benzinga Newsdesk
Apogee Therapeutics has priced its initial public offering (IPO) at $17 per share, with 17.65 million shares being offered. The IPO is currently indicating $22.10 on 321K shares.
July 14, 2023 | 2:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apogee Therapeutics' IPO has been priced at $17 per share, with the IPO currently indicating $22.10 on 321K shares.
The news of Apogee Therapeutics' IPO pricing at $17 per share and currently indicating $22.10 on 321K shares is directly related to the company and its stock. This could potentially attract investors, driving the stock price up in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100